Who Owns The Patient Relationship?

1. 📊 The Main Entry: Hartford HealthCare & K Health launch PatientGPT, a 24/7 AI bridge for patients

Hartford HealthCare and K Health have launched PatientGPT, an AI tool that gives patients secure, personalized access to their own health information. Using medical records, it allows users to ask health questions in plain language, check medication interactions, review lab results, and schedule in-person visits, all while keeping the care team in the loop via chat summaries. 

What's happening? Health systems are racing to meet patients where they already are: on AI. With 32% of adults now using tools like ChatGPT for health questions (per both Rock Health and KFF), PatientGPT is Hartford's bet on capturing that demand inside a trusted, clinically-integrated environment rather than ceding it to consumer AI. K Health, the NYC-based company behind the platform, has spent nearly a decade building clinical AI that works alongside physicians,  helping them deliver both virtual and in-person primary care more efficiently.

Why does this matter? Patients are already using AI for health questions, and consumer platforms like ChatGPT Health and Claude have the scale and system-agnostic reach to meet them there. PatientGPT isn't really competing on features, instead, it's a B2B distribution play. K Health is betting that health systems will pay to keep patients inside their ecosystem rather than cede that relationship to a general-purpose AI with no loyalty to any provider. The question isn't whether AI will navigate patient health, but who will own that interaction when it happens.

Sources: Fierce Healthcare, K Health, Hlth

2. ⭐ Healthcare Leader Spotlight

This week, we chatted with Myra Ahmad MD, a former MIT researcher who founded Mochi Health in 2022. Mochi Health is a telehealth platform that provides personalized weight loss care including access to GLP-1s and coaching by connecting patients with doctors and dietitians for virtual treatment plans. 

How is the consumer's relationship to healthcare changing?

In any other consumer space, you know what you're paying for and you know what you're getting. A good or bad experience is directly reflected in your willingness to pay. Healthcare has never worked that way, you can have a terrible provider experience and it has no bearing on provider reimbursement. That misalignment is finally starting to break down.

A critical mass of people have ended up on high-deductible plans, or have left the system entirely in favor of cash-pay coverage. Now that patients are paying directly, they have to actually enjoy the experience for it to be sustainable. The incentives are reshaping the product. 

A hundred years from now, healthcare could look something closer to a DoorDash model: a marketplace where you pick your provider, pay them directly, and browse and compare pharmacies the same way. A lot of the middlemen are reaching a breaking point. They're taking such a high fraction of total labor costs and GDP that people are starting to opt out of the system entirely, and that exodus is only accelerating.

What role does direct primary care play in this consumer health evolution?

The current experience at most traditional practices is broken in several ways - the lack of appointments, the long wait times, and no transparency in terms of payment. 

Direct primary care flips that. Patients pay their provider directly, and it's often cheaper than using insurance. They know what they're getting, they can switch if they're unhappy, and they shop from a full list of providers. For providers, compensation in traditional settings is flat, driven by the volume of insurance codes billed and the length of visits; there's no patient satisfaction component at all. Direct primary care changes that calculus: the best practices see fewer patients, invest in retention, and build something closer to the relationship that was always supposed to be at the center of medicine.

Mochi Health was really born out of the idea of making care-delivery better. We are differentiating in the GLP-1 space by really focusing on the relationship between the patient and the provider. We provide a direct primary marketplace that patients can use to select their own provider and we also have a pharmacy software for fulfillment and care management.

3. 📌 Post-its: In Case You Missed It

• Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill (MedCity News)

• White House floats 12.5% budget for Department of Healthcare and Human Services (Fierce Healthcare)

• Latent Health raises $80M for AI Medication Approval Platform (Mobi Health News)

• CMS finalizes Medicare Advantage star ratings overhaul (Healthcare Dive)

• Novo Nordisk launches discounted subscription plan for Wegovy (Forbes)

 4.  📯Shout-out to our sponsor

Shift Notes is co-produced with Inflect Capital, an early-stage healthcare fund investing from pre-seed through Series A. Inflect is backed by Vituity, a national provider network of 8,000+ clinicians serving 14 million patients annually across 30 states. If you are building a category defining healthcare solution, we’d love to hear from you: nika@inflect.health

About ShiftOS and Holly

ShiftOS is reimagining how shift-based organizations manage their most valuable asset: their people. Our flagship product, Holly, is an AI workforce management and coordination platform that automates scheduling, staffing, and operational decision-making across clinical, administrative, security, and contingent worker populations. By replacing legacy systems and fragmented point solutions, Holly gives operators real-time visibility and intelligent automation across the entire workforce — so skilled professionals can spend less time on administrative work and more time on the work they were trained to do. ShiftOS is based in San Francisco, CA and backed by top investors like Topology and Work-Bench. Request a demo →